The lipoprotein lipase (LPL) Asn291Ser polymorphism has been determined in 313 healthy subjects from Serbia. LPL variants were detected by mismatch PCR followed by RsaI restriction digestion and 5% polyacrylamide gel electrophoresis. The relationship between LPL Asn291Ser polymorphism and plasma lipid levels, and association between Asn291Ser polymorphism and arterial blood pressure were found. Significant decrease in high-density lipoprotein cholesterol levels (p<0.05) and significantly higher values of systolic blood pressure (SBP) (p<0.01) were found in females carrying the Ser291 allele. Male carriers of Ser291 allele had significantly lower levels of SBP (p<0.01). Findings from our study could be of importance for further research of pathological state regarding lipid metabolism and other risk factors of vascular diseases in Serbian population.
Introduction
Enzyme lipoprotein lipase (LPL) has a central role in lipid metabolism. LPL hydrolysis triglycerides (TG) in the core of circulating chylomicrons and very-low density lipoproteins (VLDL). Lipoprotein triglyceride is hydrolyzed to free fatty acids that are taken-up by tissues and either used as energy or reassembled into triglyceride and stored (1) . The major sites of LPL synthesis are the skeletal and cardiac muscle and adipose tissue.
The human LPL gene consists of ten exons, spans about 30kb on chromosome 8p22 (6) . About 80 naturally occurring mutations in LPL gene have been described in humans, the majority of which are missense. LPL mutations are spread over most exons; the most frequent sites of these mutations are in exons 5 and 6 (7) . Most amino-acid changing mutations in LPL are rare, either restricted to single families or isolated geographic regions (1) . Asn291Ser substitution has been identified widely, and it seems to be common in the general population (2, 3) . Amino acid change Asn291Ser is a result of A->G transition at position 1127 within exon 6 of LPL gene. Asn291Ser substitution is located in the N-terminal end and may influence the catalytic activity of LPL (4) . LPL is most active as a dimmer, composed of two identical subunits arranged in a head to tail configuration (5). Asn291Ser substitution destabilizes homodimmer formation, with a consequent loss of lipolytic activity (3).
Based on a meta-analysis, heterozygote frequencies in population-based studies ranged from 1'7 % (8). The Ser291 variant in general population is associated with an increase in plasma triglycerides, and decrease in high-density lipoprotein (HDL) cholesterol concentrations (9, 10) . The aim of this study was to confirm the presence of Asn291Ser polymorphism in the human LPL gene, to determine genotype and allele frequencies of Asn291Ser polymorphism in Serbian population and relationship between this polymorphism and both plasma lipid and blood pressure levels.
Material and Methods

Subjects and study design
The epidemiological study was performed in a population-based sample of Caucasian subjects from Serbia. Informed consent was obtained from each participant in the study. Personal data (age, sex, weight, height and blood pressure) were obtained from all participants. Blood pressure (BP) was measured in the sitting position after a 15-minute rest. It was read three times by mercury sphygmomanometer and the mean value of these measurements was used. A questionnaire was designed to obtain relevant social (smoking, alcohol consumption, physical activity), medical (general health, cardiovascular state, physician visits), and family (general health and cardiovascular status of parents and siblings) history. All subjects with a personal or family history of cardiovascular diseases, diabetes and thyroid dysfunction were excluded. Individuals taking any drug with lipid lowering effects were also excluded.
Blood samples were obtained from 313 healthy, unrelated individuals (144 women and 169 men), collected from participants after 12 hours of fasting. The total plasma cholesterol and TG levels were determined on Monarch Plus apparatus (Instrumentation Laboratory, Lexington, USA) using enzymatic colorimetric methods. HDL cholesterol was determined after dextran sulfate-Mg 2+ precipitation of VLDL and low-density lipoprotein (LDL) cholesterol; using CHOD-PAP method. LDL cholesterol was calculated according to the Friedwald's formula (11) for participants with TG levels < 4.5 mmol/L. All reagent kits were provided by Instrumentation Laboratory (Lexington, USA). Characteristics of the population are shown in Table I .
DNA analysis
Genomic DNA was purified by the proteinase K/phenol extraction method, as previously described (12) , from the whole blood samples collected with EDTA as anticoagulant. DNA segment contained within exon 6 of LPL gene was amplified by mismatch polymerase chain reaction (PCR) in Touch Down TM (Hybaid, Teddington, UK). Genotypes of LPL Asn291-Ser polymorphism were determined after RsaI restriction digestion (13), on a 5% polyacrylamide gel (PAA).
Statistical analysis
Frequencies of LPL alleles were estimated by the gene counting method. Chi-square statistics was used to test fit goodness to the Hardy-Weinberg's equilibrium. A one-way analysis of variance (ANOVA) was performed separately in both men and women to test the null hypothesis of equality of lipid and/or BP levels between LPL genotypes. We considered statistical significance to be at the 0.05 levels. Due to skewed distribution of both HDLC and TG, all TG and HDLC analysis were performed on logarithmically transformed values. All lipid and BP values were adjusted to remove the effects of a set of significant covariates (age, body mass index (BMI) and cigarette smoking). 
Results
LPL genotype and allele frequencies
Relative frequencies of LPL alleles and genotypes in a sample of 313 healthy subjects from Serbia are shown in Table II . Allele frequencies of Asn291/Ser291 were 0.984/0.016. The observed LPL genotype frequencies were in the Hardy-Weinberg's equilibrium.
Association of LPL polymorphism with serum lipid levels and BP values
Adjusted means of serum lipid levels (total cholesterol, HDL cholesterol, LDL cholesterol and TG) according Asn291Ser genotypes are shown in Table  III . Subjects with genotype Asn291Asn had higher levels of total, LDL cholesterol and HDL cholesterol compared with subjects with Asn291Ser genotype, but statistical significance was not reached (p>0.05). There was no significant difference in triglycerides and BP levels between two genotypes in the whole sample (p>0.05).
In males with Asn291Asn genotype levels of both total and LDL cholesterol were higher than in those with Asn291Ser genotype (p>0.05). No significant difference (p>0.05) was found in TG and DBP levels between two genotypes. SBP level was significantly higher in males with Asn291Asn compared to those with Asn291Ser LPL genotype (p<0.05). 
Discussion
Asn291Ser LPL polymorphism has been determined for the first time in healthy and unrelated subjects from Serbia. It has been found that the frequency of this polymorphism varies in different ethnic groups (14) . Genotype frequencies of Asn291Ser polymorphism in our population correspond to those reported for Caucasian populations (9, 15, 16, 18, 20, 21) (Table IV) .
The relation between Asn291Ser LPL polymorphism and HDL cholesterol level in healthy individuals has been reported in various studies. In some it has been significantly decreased (10, 16) but in the others insignificantly changed (9) . In this study a trend to decrease in HDL cholesterol level among heterozygous carriers of Asn291Ser substitution in the whole population sample and among men, was more pronounced and reached statistical significance in females. The observed more emphasized effect of Asn291-Ser polymorphism on HDL cholesterol in females is in accordance with the results of a previous study, where HDL cholesterol has been found to be significantly decreased (10) . Variation of triglyceride levels between individuals with different LPL genotypes in our population was not statistically significant. Previous reports have found significant increase in triglyceride levels of carriers of Asn291Ser polymorphism (9), or only a trend to the increase (16) .
The association between lipoprotein lipase gene Asn291Ser polymorphism and BP levels in a healthy (random) population was not examined until now. In our study of Serbian population relationship between LPL Asn291Ser polymorphism genotypes and blood pressure levels was in opposite manner between genders. Recently, a study of pre-eclamptic women revealed a significantly increased frequency in Asn291Ser genotype compared to pregnancy controls (17) . In our study female carriers of Ser291 allele had significantly higher levels of SBP (p=0.009). On the contrary, in male subjects with Asn291Ser LPL genotype SBP values were significantly lower compared to the other genotype (p=0.008). Differences in the effects of Asn291Ser substitution that were observed among women and men suggest a possible modulation of LPL expression by hormonal or lifestyle factors.
Since the carriers of Asn291Ser genotype are rare in population, future studies require examination of a larger sample. However, data from our study are of importance for further research of pathological state regarding lipid metabolism and other risk factors of vascular diseases in Serbian population. 
